Anne-Marie Duliege
2016
In 2016, Anne-Marie Duliege earned a total compensation of $1.1M as Executive Vice President, Chief Medical Officer at Rigel Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $120,205 |
|---|---|
| Option Awards | $604,800 |
| Salary | $358,197 |
| Other | $62,795 |
| Total | $1,145,997 |
Duliege received $604.8K in option awards, accounting for 53% of the total pay in 2016.
Duliege also received $120.2K in non-equity incentive plan, $358.2K in salary and $62.8K in other compensation.
Rankings
In 2016, Anne-Marie Duliege's compensation ranked 7,571st out of 14,075 executives tracked by ExecPay. In other words, Duliege earned more than 46.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,571 out of 14,075 | 46th |
Division Manufacturing | 2,870 out of 5,486 | 48th |
Major group Chemicals And Allied Products | 946 out of 1,900 | 50th |
Industry group Drugs | 732 out of 1,543 | 53rd |
Industry Pharmaceutical Preparations | 583 out of 1,173 | 50th |
Source: SEC filing on March 29, 2017.
Duliege's colleagues
We found four more compensation records of executives who worked with Anne-Marie Duliege at Rigel Pharmaceuticals in 2016.